AKT1 and breast cancer: Furthermore, a study by Ma et al. (2025) showcased the role of SLC26A9 in breast cancer, indicating that it promotes tumor cell proliferation and metastasis through the PI3K/AKT signaling pathway (Ma et al., 2025).